Cell proliferation, apoptosis, and expression of cyclin D1 and cyclin E as potential biomarkers in tamoxifen-treated mammary tumors.
- 1 February 2003
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 77 (3) , 253-264
- https://doi.org/10.1023/a:1021804121171
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Neoplastic transformation of mammary epithelial cells in rats is associated with decreased apoptotic cell deathCarcinogenesis: Integrative Cancer Research, 2000
- Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trialThe Lancet, 1999
- Tamoxifen in the Treatment of Breast CancerNew England Journal of Medicine, 1998
- Cyclins and breast cancerJournal of Mammary Gland Biology and Neoplasia, 1996
- Deregulated expression of cyclin D1 and other cell cycle-related genes in carcinogen-induced rat mammary tumorsCarcinogenesis: Integrative Cancer Research, 1995
- Mitotic activity, apoptosis and TRPM‐2 mRNA expression in dmba‐induced rat mammary carcinoma treated with anti‐estrogen toremifeneInternational Journal of Cancer, 1993
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992
- A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysisCytometry, 1990
- Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomataPublished by Elsevier ,1976
- Mammary Cancer Induced by a Single Feeding of Polynuclear Hydrocarbons, and its SuppressionNature, 1961